Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUCCEED: Preoperative CAPOX after colonic stent placement in obstructive colon cancer
jRCTs051240077Recruiting
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of capecitabine and oxaliplatin in colon cancer and colorectal cancer (CRC). Primary endpoint: Perioperative severe complication rate. Started Jun 2024; status: recruiting.
02
Drugs
capecitabineoxaliplatin
03
Conditions
colon cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on jRCTs051240077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240077.